CD14

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 5, 1999, Pages 545-549

  Schütt, Christine ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Endotoxin receptor; Innate immunity; Sepsis

Indexed keywords

CD14 ANTIGEN; CELL SURFACE PROTEIN; GAMMA INTERFERON; GLYPICAN; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BINDING SITE; BONE MARROW CELL; CONTROLLED STUDY; EPITHELIUM CELL; GENETIC ANALYSIS; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; LIGAND BINDING; MACROPHAGE; MOUSE; MUTATION; PARACRINE SIGNALING; PHAGOCYTOSIS; PROTEIN EXPRESSION; SEPSIS;

ANIMALS; ANTIGENS, CD14; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; RECEPTORS, IMMUNOLOGIC; SEPSIS;

EID: 0344348974     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00153-8     Document Type: Article

References (15)

1. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1990;1431-1433.
2. Rietschel E.T., Kiriakae T., Schade F.U., Mamat U., Schmidt G., Loppnow H., Ulmer A.J., Zähringer U., Seydel U., Di Padova F., Schreier M., Brade H. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8:1994;217-225.
3. Stelter F., Bernheiden M., Menzel R., Jack R.S., Witt S., Fan X., Pfister M., Schütt C. Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. Eur. J. Biochem. 243:1997;100-109.
4. Downey H.S., Han J. Cellular activation mechanisms in septic shock. Front Biosci. 3:1998;468-476.
5. Joseph C.K., Wright S.D., Bornmann W.G., Randolph J.T., Kumar E.R., Bittmann R., Lin J., Kolesnick R.N. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. J. Biol. Chem. 269:1994;17606-17610.
6. Petty H.R., Todd R.F. Integrins as promiscuous signal transduction devices. Immunol. Today. 17:1996;209-211.
7. Jack R.S., Fan X., Bernheiden M., Rune G., Ehlers M., Weber A., Kirsch G., Menzel R., Fürll B., Freudenberg M., Schmitz G., Stelter F., Schütt C. Lipopolysaccharide binding protein is required to combat a murine Gram-negative bacterial infection. Nature. 389:1997;742-745.
8. Medzhitov R., Janeway A. Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 91:1997;295-298.
9. Pugin J., Heumann D., Tomasz A., Kravchenko V.V., Akamatsu Y., Nishijima M., Glauser M.P., Tobias P.S., Ulevitch R.J. CD14 is a pattern recognititon receptor. Immunity. 1:1994;509-516.
10. Grunwald U., Fan X., Jack R.S., Workalemahu G., Kallies A., Stelter F., Schütt C. Monocytes can phagocytose Gram-negative bacteria by a mechanism dependent on CD14. J. Immunol. 157:1996;4119-4125.
11. Savill J. Phagocytic docking without shocking. Nature. 392:1998;442-443.
12. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2 and PAF. J. Clin. Invest. 101:1998;890-898.
13. Yu B., Hailman E., Wright S.D. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J. Clin. Invest. 99:1997;315-324.
14. Haziot A., Ferrero E., Kontgen F., Hijiya N., Yamamoto S., Silver J., Stewart C.L., Goyert S.M. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity. 4:1996;407-414.
15. Volk H.D., Reinke P., Krausch D., Zuckermann H., Asadullah K., Müller J.M., Döcke W.D., Kox W.J. Monocyte deactivation: rationale for a new therapeutic strategy in sepsis. Int. Care Med. 22:1996;474-481.